Detalles de la búsqueda
1.
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
Ann Surg Oncol
; 30(3): 1312-1326, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335273
2.
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
BJOG
; 130(12): 1437-1450, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37132126
3.
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.
Int J Gynecol Cancer
; 33(6): 982-987, 2023 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37045546
4.
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.
Carcinogenesis
; 42(6): 785-793, 2021 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34037709
5.
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas.
Gynecol Oncol
; 163(1): 130-133, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452747
6.
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.
Gynecol Oncol
; 160(3): 786-792, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33375991
7.
Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Gynecol Oncol
; 157(2): 514-520, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32199636
8.
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Gynecol Oncol
; 159(1): 214-220, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709535
9.
Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
Gynecol Oncol
; 156(3): 517-522, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883735
10.
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.
Gynecol Oncol
; 156(2): 407-414, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31839337
11.
An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions.
Int J Gynecol Pathol
; 39(3): 261-269, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31033800
12.
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
BMC Cancer
; 19(1): 648, 2019 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31266460
13.
Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
Gynecol Oncol
; 153(1): 192-200, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30661763
14.
Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma.
Gynecol Oncol
; 153(2): 217-222, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30803719
15.
ASO Visual Abstract: Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
Ann Surg Oncol
; 30(3): 1329-1330, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414905
16.
Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma.
Gynecol Oncol
; 148(2): 281-285, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233532
17.
Genetic characterization of early onset ovarian carcinoma.
Gynecol Oncol
; 140(2): 221-5, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26718727
18.
Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma.
Gynecol Oncol
; 143(2): 389-392, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27575909
19.
Challenges in the identification of inherited risk of ovarian cancer: where should we go from here?
Gynecol Oncol
; 152(1): 3-6, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30538055
20.
53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.
Gynecol Oncol
; 128(3): 493-9, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23246380